Dataset Information


Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice.

ABSTRACT: OPINION STATEMENT:New developments in eosinophilic esophagitis (EoE) pathogenesis are shaping our current therapeutic and management strategies. EoE is a chronic allergic inflammatory disease with progression to fibrostenotic disease. The disease warrants early diagnosis and long-term maintenance therapy. The diagnosis of EoE should be based on the concept of an allergy-mediated disease with esophageal dysfunction and esophageal eosinophilia. Recent findings suggest that proton pump inhibitor (PPI)-responsive esophageal eosinophilia (PPI-REE) is likely a continuum of EoE or a similar T-helper 2 (Th2)-mediated allergic process. PPIs have therapeutic properties that can benefit both gastroesophageal reflux disease (GERD) and EoE. Therefore, PPIs should be considered not a diagnostic tool but, rather, a therapeutic option for EoE. If patients are PPI nonresponsive, then dietary therapy or steroid therapy should be considered. Dilation can be reserved as adjuvant therapy for severe fibrostenotic lesions.


PROVIDER: S-EPMC4329259 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4289084 | BioStudies
2016-01-01 | S-EPMC4734951 | BioStudies
2017-01-01 | S-EPMC5509802 | BioStudies
| S-EPMC6174113 | BioStudies
2019-01-01 | S-EPMC6855320 | BioStudies
| S-EPMC4599711 | BioStudies
2018-01-01 | S-EPMC5988195 | BioStudies
2018-01-01 | S-EPMC6132253 | BioStudies
1000-01-01 | S-EPMC4644096 | BioStudies
1000-01-01 | S-EPMC4816096 | BioStudies